India's first homegrown MRNA vaccine to be tested amid Omicron spike: Official sources
Shortpedia
Content Team
Image Credit: mid day
The country's first messenger mRNA vaccine is expected to begin trials on humans in February. The Pune-based Gennova Biopharmaceuticals has submitted phase 2 data of mRNA vaccine and has also completed the recruitment of phase 3 data. Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) is expected to review the data soon, the official sources said.
